EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes

Mahtab Dastpak, Claudia A Mimoso, Moein Farshchian, Christina L Paraggio iD, Claudia E Leonard, Shanye Yin, Binkai Chi, Kelsey W Nassar, R Grant Rowe, Jiuchun Zhang, Zhonggang Hou, George Q Daley und 2 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0334361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mahtab Dastpak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Harvard Medical School, Boston, Massachussetts, United States of America. Hauptthemen laut MEDLINE: RNA Splicing Factors, Human Embryonic Stem Cells, Phosphoproteins, Mutation. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH, Boston Children's Hospital Office of Faculty Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SF3B1, a component of the U2 snRNP pre-mRNA splicing factor, plays a critical role in splicing and is frequently mutated in cancer, particularly hematologic malignancies. We investigated the effects of the most common SF3B1 mutation, heterozygous substitution of Lysine 700 to Glutamate (K700E), in human embryonic stem cells (hESC), using CRISPR-Cas9 to generate heterozygous SF3B1 K700E clones. Interestingly, we observed the upregulation of several key transcription regulators associated with hematopoiesis and a broad range of immune genes in SF3B1 K700E hESCs. Despite differences in the transcriptional and splicing profiles between hESC and myelodysplastic syndrome (MDS) cells harboring the SF3B1 K700E mutation, several common immune gene programs were identified in both cell types. To elucidate the molecular mechanisms underlying dysregulated gene expression in SF3B1 K700E hESCs, we mapped actively engaged RNA polymerase II (RNA Pol II) using Precision Run-On sequencing (PRO-seq). These analyses revealed that the SF3B1 K700E mutation alters RNA Pol II elongation properties. Specifically, we observed a general increase in pause release in SF3B1 K700E hESCs, consistent with recent work in leukemia cells suggesting that the SF3B1 K700E mutation affects early transcription elongation. Taken together, our study identifies several candidate genes that could contribute to the SF3B1 mutated phenotype and clarifies the role for the U2 snRNP and pre-spliceosome assembly on transcription by RNA Pol II. Further, our data suggest that mutations of SF3B1 impact immune gene expression independent of cell type, providing new insights into the role of SF3B1 K700E in hematologic malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsHuman Embryonic Stem CellsPhosphoproteinsMutationHumansRNA Polymerase IIMyelodysplastic SyndromesGene Expression RegulationCell LineRNA Splicing

Substanzen

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsRNA Polymerase II

Autor:innen und Institutionen

  • Department of Cell Biology, Harvard Medical School, Boston, Massachussetts, United States of America.
  • Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachussetts, United States of America.
  • Division of Oncology, Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
  • Boston Children's Hospital, Harvard Medical School, Boston, Massachussetts, United States of America.
  • Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachussetts, United States of America.

ORCID-Profile: Christina L Paraggio, Karen Adelman

Förderung

  • NIGMS NIH HHS
  • NIH
  • Boston Children's Hospital Office of Faculty Development

Zitieren

APA

Dastpak, M., Mimoso, C. A., Farshchian, M., Paraggio, C. L., Leonard, C. E., Yin, S., Chi, B., Nassar, K. W., Rowe, R. G., Zhang, J., Hou, Z., Daley, G. Q., Adelman, K., & Reed, R. (2025). SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes. PLOS One. https://doi.org/10.1371/journal.pone.0334361

Vancouver

Dastpak M, Mimoso CA, Farshchian M, Paraggio CL, Leonard CE, Yin S, et al. SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes. PLOS One. 2025. doi:10.1371/journal.pone.0334361

BibTeX
@article{Dastpak2025,
  author = {Dastpak, Mahtab and Mimoso, Claudia A and Farshchian, Moein and Paraggio, Christina L and Leonard, Claudia E and Yin, Shanye and Chi, Binkai and Nassar, Kelsey W and Rowe, R Grant and Zhang, Jiuchun and Hou, Zhonggang and Daley, George Q and Adelman, Karen and Reed, Robin},
  title = {SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334361}
}
Kostenlos starten →